QA: MIRA Pharmaceuticals INC in us_pharma/2025

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001904286_2026_MIRA_Pharmaceuticals_INC.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001904286, MIRA Pharmaceuticals INC

  xvar xval
0 AssetsCurrent 11,058,166
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 35,439
4 LiabilitiesCurrent 702,068
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 8,773,329
9 ResearchAndDevelopmentExpense 1,719,783
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 50,627
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 11,093,605
1 Liabilities 702,068
2 Expenses 10,493,112
3 Revenues 0
4 StockholdersEquity 10,391,537
5 NetIncome -10,442,485
6 ComprehensiveNetIncome -10,442,485
7 BaseVar 11,169,706
8 EconomicCapitalRatiobeforeLimitedLiability 2.07
9 EconomicCapitalRatio 3.07

Edgar->Model Mapping

Feature Distribution

Change over Time